Articles from Neuvasq Biotechnologies

Neuvasq Presents Data Showcasing Promising Novel Multispecific Gpr124-Targeting Antibodies for Blood Retina Barrier Restoration at ARVO 2026

Gosselies, Belgium, May 05, 2026 (GLOBE NEWSWIRE) --

By Neuvasq Biotechnologies · Via GlobeNewswire · May 5, 2026

Articles from Neuvasq Biotechnologies | MarketMinute